Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 June 2020 | Story Rulanzen Martin | Photo Rulanzen Martin
Prof Kobus Marais, the founder of the JTSA, at the launch of his Indexicality Research Forum in 2019.

The newly launched Journal for Translation Studies in Africa (JTSA) by Prof Kobus Marais from the Department of Linguistics and Language Practice at the University of the Free State (UFS), is the result of various efforts over a period of more than a decade.

“The first Summer School for Translation Studies in Africa 2009 stands out as one of the first efforts to think about the concept of translation in Africa,” said Prof Marais. A subsequent series of summer schools also led to the formation of the Association for Translation Studies (ATSA) in Africa in 2016 in Nairobi, Kenya. 

The journal is an open-sourced, peer-reviewed publication, boasting scholarly papers, book reviews, opinion pieces and work by young scholars within translation studies. The first edition of the journal was made possible with financial support from Prof Corli Witthuhn, Vice-Rector: Research, Innovation and Internationalisation and the Directorate: Research Development at the UFS. 


First edition to focus on African translation phenomena 

The JTSA is an attempt to start scholarly debate with a focus on Africa as a developmental context in which to study translation phenomena and practices. The first edition will guest edited by Dr Carmen Delgado Luchner from the University of Geneva who is an accredited European Union interpreter. In the editorial of the first edition, Prof Marais and Dr Delgado Luchner set out the vision of the journal, namely: “to offer a high-level publication outlet to translation-studies scholars from Africa, African translation-studies scholars in the diaspora and scholars in general working on African topics in translation studies”.

“It would disseminate their work in order to advance the field of translation studies in Africa and to position Africa in relation to the rest of the world as far as translation studies are concerned.”

The editorial board of the JTSA consists of Prof Kobus Marais, the editor-in-chief, who will be assisted by three sub-editors, who each take responsibility for one of the sections. They are: Dr Francis Ajayi – Agenda (opinion pieces); Dr Felix Awung – reviews; and Dr Mwamba Chibamba – New Voices (young scholars). 

Apart from the editorial board there is an International Advisory Board consisting of various translation scholars. “This journal will be devoted to translation studies in Africa, with its wealth of languages, its innovative and creative language and translation practices and policies,” said Prof Reine Meylaerts, Vice-Rector: Research Policy at Katholieke Universitiet Leuven, who serves on the advisory board. She also praised the JTSA for its multilingualism and being an example of Open Science. 

Other scholars on the advisory board are: Prof Rita Kothari (Ashoka University in India); Prof John Milton (University of São Paulo, Brazil); Prof Jacobus Naude (UFS); Prof Maria Tymoczko (University of Massachusetts, Amherst); and Prof Rita Wilson (Monash University). 

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept